(Only select if your attended FCOM in-person)
(Only select if your attended FCOM in-person)
(Only select if you attended FCOM virtually)
All continuing education credits should be submitted at the conclusion of the meeting, no later than November 30th.
How to keep track of your sessions for CME and CEU submission:
Each attendee will type the session codes associated with the courses that were attended into the CME/CEU submission form. Attendees can track their sessions manually in the FCOM Program Guide, or when logged in to the conference app, click the heart icon in the top to add sessions to your personal agenda for reference.
At the conclusion of the meeting, follow the “How to Submit” step-by-step instruction sheet provided at the Registration Desk or visit www.FCOMnow.com/CE2022
The Network of Medical Audiology Professionals is approved by the American Academy of Audiology to offer Academy CEUs for this activity. The program is worth a maximum of 2.15 CEUs. Academy approval of this continuing education activity is based on course content only and does not imply endorsement of course content, specific products, or clinical procedure, or adherence of the event to the Academy’s Code of Ethics. Any views that are presented are those of the presenter/CE Provider and not necessarily of the American Academy of Audiology.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical Educational Council of Pensacola (MECOP), the Florida Society of Otolaryngology and the Network of Florida Otolaryngologists.
MECOP is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Educational Council of Pensacola designates this activity for a maximum of 12.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Medical Educational Council of Pensacola (MECOP) requires that all speakers, faculty members and planning members complete its disclosure and conflict of the interest resolution process. MECOP requires that all relevant relationships with ineligible companies are disclosed to the learners. Any speaker, planner, or author of content for this activity that has disclosed a relevant relationship submitted to MECOP’s COI resolution process prior to the beginning of this activity.
The following faculty/speakers/panelists do not have any relevant relationships with ineligible companies to disclose:
Adrien Eshragi, MD
Amanda Schaefer, MS, LGC
Amy Rutt, D.O.
Aniket Saoji, PhD
Anurag Agarwal, MD
Ari Wirtschafter, MD
Brad Stach, PhD
Bridgitte Shaw, MMS, PA-C
Camille Dunn, PhD
Camysha Wright, MD
Carlos Torre, MD
Chris Danner, MD
Corinne Levine, MD, MPH
Daniel Romero, PhD
Daniel Vincent, MD
Danny Mistry, MD
David Rosow, MD
Dennis Poe, MD
Devin McCaslin, PhD
Eliot Shearer, MD, PhD
Faisal Merchant, MD
Ira Papel, MD
Kinneret Ron, APRN
Jaclyn Klimzcak, MD
James Benson, MS
James Denneny, MD
Jeffrey Johnson, MD
Jeffrey McFarlane, ARNP
Jennifer Shinn, PhD
Jessica Ward, ARNP
Jose Mercado, PA-C
Juan Chiossone, MD
Julie Daugherty, PhD, NP-C
Kestutis Boyev, MD
Leslie Kim, MD, MPH
Liliana Ein, MD
Mark Parker, PhD
Mark Widick, PhD
Matt Bush, MD, PhD
Matthew Mifsud, MD, FACS
Melissa Hancock, MD
Natalie Phillips, AuD
Nathan Nachlas, MD
Neil Chheda, MD
Osarenoma Olomu, MD
The following faculty/speakers and panelists have relevant relationships with ineligible companies as follows:
Adrien Eshraghi, MD discloses that he is in a research grant for Mechel Corporation
A.U. Bankaitis, PhD discloses that she is employed by Oaktree products.
Aly Hoffman, AuD discloses that she is employed by Phonak.
Amanda Reed, AuD discloses that she is employed by Signia
Boyd Gillespie, MD discloses that he is a consultant for Medtronic, Nyxoah and is also on research support for both as well as Inspire Medical. Mr. Gillespie has also disclosed that he is on the scientific advisory board for CryOSA and Alfred Mann Foundation (self)
Christine Franzese, MD discloses that she is a speaker for GSK, Astra Zenecei, Regeneron/Sao fi, and Genetech, Optihron. Dr. Franzese also disclosed that she is a part of the research funding for Merck, Shiniogi, Bellus, Bio Haven, and Lyra (self)
Christopher Nickel, MD discloses being a consultant for DePuy Synthes (self)
Clark Rosen, MD discloses being a consultant for Olympus America and Fredodenbag. Dr. Rosen has also disclosed having a relationship with Instromentrium and Reflux Gourmet.
Curtis Johnson, D.O. discloses that he is a Aerin Medical Consultant (self)
Dave Fabry, PhD discloses that he is an employee of Starkey, and a non-paid Envoy Medical Board Member.
David Kennedy, MD discloses that he is a Consultant for GSK, Stryker, Medtronic, and Neurent (self)
Dennis Poe, MD discloses being a consultant for both Acclarent and Stryker
Elina Toskala, MD discloses she is a consultant for both GSK and Medtronic. Dr. Toskala also funds research for Optinose
Jeb Justice, MD discloses that he is a Consultant of Intersect ENT and Medtronic (self)
Jeff Hopkins, MD discloses that he is an employee of Johnson & Johnson
Joseph Han, MD discloses that he is a Consultant of Sanofi, Regeneron, AstraZeneca, Aerin, and GlaxoSmithKline (self)
Julia Toman, MD discloses that she is a speaker/consultant for Mimedix
Kari Smilsky, AuD discloses that she is a MED-EL Member of the Audiology Advisory Board
Keeley Layfield, AuD discloses that she is an employee of Starkey
Kevin Brown, MD discloses that he is a MED-EL, AB and Cochlear Consultant
Lisa Park, AuD discloses that she is a MED-EL Consultant and Research Grant (self)
Marc Dean, MD discloses that he is a Biosense Webster and Acclarent Consultant, Immertec Consultant, Stryker PI Study, Aerin and Ststent Consultant, and CMO for Employer Direct (self)
Maria Suurna, MD discloses that she is consulting for Nyxoah, as well as is consulting and on the medical advisory board for Inspire Medical and Medtronic
Mark Tabor, MD discloses that he is a consultant for Medtronic
Matt Brokaw discloses that he is the President and CEO of Aerin Medical
Matthew Schmitt, MD discloses that he is a consultant for Zoll Itamar Corporation (self)
Melynda Barnes, MD discloses that she is an employee of RO
Michael Benninger, MD discloses that he is a Thermo-Fisher Consultant (self)
Michael Hoa, MD discloses that he is a Cochlear and Cook Medical Consultant
Molly Smeal, AuD discloses that she is a Cochlear Consultant
Myka Whitman, RN discloses that she is an employee of MedPro Group
Patrick Antonelli, discloses that he is an employee of UpToDate and Janssen Pharma (self)
Peter Catalano, MD discloses that he is a Hemostasis Consultant (self)
Richard Harvey, MD discloses that he is a Consultant for Medtronic, NRILMED, and SANOFF. Dr. Harvey also has disclosed that he is a speaker and a part of the board for ASK, MEDA, Seqirisp, Stallirgenes (self)
Sarah Wise, MD discloses that she is on the advisory board for OptiNose, Genentech, and ALK-Abello. Dr. Wise also disclosed being a consultant for Neurent and Chitogel
Spencer Payne, MD discloses that he is on the Advisory Board for Genetech. Dr. Payne also disclosed research study for Astra-Zeneca and Cumberland Pharm.
Susan de Bondt, AuD discloses that she is an employee of Widex
Valerie Kadem, AuD discloses that she is an employee of ReSound
William Facteau discloses that he is an employee of Earlens
William Reisacher, MD disclosed being an advisor/shareholder for Allovate and Intrommune